Synthasome

Synthasome is a private, commercial-stage medical device company operating in the regenerative medicine and orthobiologics sector. Its flagship product, X-Repair, is an FDA 510(k)-cleared, synthetic, biodegradable surgical mesh used to reinforce tendon repairs, such as in rotator cuff injuries. The company leverages bioengineering and tissue engineering principles to develop products with mechanical properties similar to native tissue, offering a reliable alternative to biological grafts. Synthasome appears to be in an early revenue phase, commercializing its first product while continuing R&D for new applications in tendon, ligament, and cartilage repair.

Synthetic polymer bioengineering platform for creating degradable surgical meshes with tailored mechanical properties (e.g., high tensile strength, suture retention) that mimic native soft tissue, act as a scaffold for tissue in-growth, and provide reinforcement during healing.

X-Repair competes in the tendon reinforcement market against biologic grafts (human allografts and animal-derived xenografts) from companies like Arthrex, Smith & Nephew, and Stryker, as well as other synthetic scaffolds. Its primary differentiation is its engineered mechanical strength, synthetic consistency, and lack of biological donor risks. For future cartilage programs, competition would include cell-based therapies, osteochondral allografts, and other synthetic implants.